TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
10x Genomics Sweden AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
256,284
|
159,178
|
77,608 |
Financial expenses |
8
|
12
|
839 |
Earnings before taxes |
135,830
|
75,387
|
23,751 |
EBITDA |
145,361
|
78,185
|
28,643 |
Total assets |
260,403
|
135,638
|
65,389 |
Current assets |
232,185
|
108,511
|
46,196 |
Current liabilities |
56,206
|
39,174
|
29,123 |
Equity capital |
204,197
|
96,464
|
36,266 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
45
|
38
|
20 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
78.4%
|
71.1%
|
55.5% |
Turnover per employee |
5,695
|
4,189
|
3,880 |
Profit as a percentage of turnover |
53.0%
|
47.4%
|
30.6% |
Return on assets (ROA) |
52.2%
|
55.6%
|
37.6% |
Current ratio |
413.1%
|
277.0%
|
158.6% |
Return on equity (ROE) |
66.5%
|
78.2%
|
65.5% |
Change turnover |
97,106
|
81,570
|
31,111 |
Change turnover % |
61%
|
105%
|
67% |
Chg. No. of employees |
7
|
18
|
12 |
Chg. No. of employees % |
18%
|
90%
|
150% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.